Cancer is the second leading cause of death in the U.S and metastatic disease remains predominantly incurable. New cancer cases and healthcare costs continue to increase year-over-year. Precision medicine aims to select the most effective treatments for patients, but existing approaches only benefit a minority of patients.
This Startup Just Raised $70 Million to Grow Tiny Tumors That Create Personalized Cancer Treatments
Forbes , July 8, 2021–
Around seven out of ten cancer patients don’t respond to drugs in the first go. This is a hard-hitting statistic for Xiling Shen, who lost his uncle to metastatic colorectal cancer. “Cancer patients are kind of like lab rats. You try different drugs on them. One doesn’t work, so you try another one,” says Shen, a researcher at Duke University. His startup, Xilis, is on a journey to find the most effective drugs for every cancer patient, without turning them into guinea pigs.